On Monday, Shares of Qiagen NV (NASDAQ:QGEN), inclined 1.10% to $26.73, during its last trading session.
Frankfurt Prime Standard: QIA, declared the launch of a new QIAGEN hereditary disease solution for research labs to accelerate solve rates in diagnostic odyssey cases, while freeing up time and resources by enabling researchers to directly focus on the right causal candidates. The offering comprises QIAGEN’s Biomedical Genomics Workbench, Biomedical Genomics Server Solution, Ingenuity® Variant Analysis™, and HGMD® Human Gene Mutation Database. The new end-to-end solution is rolling out this week at the American Society for Human Genetics (ASHG) Annual Meeting in Baltimore.
“QIAGEN continues to expand our solutions to enable the incredible advances that clinical research labs are making every day, particularly in next-generation sequencing for hereditary diseases,” said Dr. Laura Furmanski, Head of QIAGEN’s Bioinformatics Business Area. “By providing the market’s most comprehensive biomedical content, more than 10 million findings in our QIAGEN Knowledge Base, and the benefits of 16 years of experience in expert curation, we ensure the highest-quality analysis and interpretation - assisting customers move from Sample to Insight.”
QIAGEN N.V. provides sample to insight solutions that transform biological samples into valuable molecular insights worldwide. It offers sample technologies to isolate, purify, and stabilize nucleic acids and proteins in plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technologies to detect molecular targets.
At the end of Monday’s trade, Shares of Finish Line Inc (NASDAQ:FINL), gained 1.92% to $19.69.
Athletic retailer The Finish Line, Inc. (FINL) has declared the introduction of a new brand position – ‘EPIC FINISH’ – designed to drive consumer awareness and preference for Finish Line as the destination for the latest and greatest sneakers.
“The EPIC FINISH position speaks directly to the attitudes and preferences of our core consumer surrounding the culture, innovation and style of sneakers,” said Michael Grimes, vice president of omnichannel marketing for Finish Line.
This reflects Finish Line’s long-term commitment to surpassing the expectations of recently’s Millennial and Gen Z sneaker consumer through product, service and the overall omnichannel experience. It also signifies Finish Line’s commitment to an ongoing investment in brand awareness, store experience and the continued development of industry leading digital and customer relationship administration capabilities.
The Finish Line, Inc., together with its auxiliaries, operates as a specialty retailer of athletic shoes, apparel, and accessories in the United States. It operates Finish Line stores that offer athletic shoes, in addition to apparel and accessories for men, women, and kids.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.